5,7-dichloro-1H,4H-pyrido[4,3-d]pyrimidin-4-one, 95+%, 1g

Plan PLPHi S40x/0,65 contraste de fase IOS objetivo corregido al infinito

1-Cyclohexyl-2,2,2-trifluoro-ethanone, 90.0%, 10g

4-Amino-5-bromo-2-chloropyrimidine, 95.0%, 10g

2,5-Dihydro-1H-pyrrole hydrochloride, 95.0%, 25g

Carboxy-PEG4-phosphonic acid, 250mg

Pyrimidine, 2-(4-bromophenyl)-4,6-dichloro-, 97%, 5g

2-Amino-6-bromophenol, 95.0%, 500g

5-Bromo-2-methylthiazole, 95.0%, 1g

tert-Butyl (3-bromocyclobutyl)carbamate, 98%, 1g

N-propionylalanine, 95.0%, 1g

Tert-butyl 3-chloropropanoate, 98+%, 250mg

2,5-dimethyl-1H-pyrrole-3-carbaldehyde, 95.0%, 10g